RxSight Inc (RXST) USD0.001

Sell:$25.10Buy:$26.89$0.85 (3.26%)

Prices delayed by at least 15 minutes
Sell:$25.10
Buy:$26.89
Change:$0.85 (3.26%)
Prices delayed by at least 15 minutes
Sell:$25.10
Buy:$26.89
Change:$0.85 (3.26%)
Prices delayed by at least 15 minutes

Company Information

About this company

RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.

Key people

Ron M. Kurtz
President, Chief Executive Officer, Director
Shelley B. Thunen
Chief Financial Officer
Ilya Goldshleger
Chief Operating Officer
Eric Weinberg
Chief Commercial Officer
J. Andy Corley
Independent Chairman of the Board
Julie B. Andrews
Independent Director
Juliet Tammenoms Bakker
Independent Director
Tamara R. Fountain
Independent Director
William J. Link
Independent Director
Click to see more

Key facts

  • EPIC
    RXST
  • Location
    United States
  • Sector
    Capital Goods
  • Industry
    Misc. Capital Goods
  • ISIN
    US78349D1072
  • Market cap
    $1.03bn
  • Employees
    498
  • Shares in issue
    40.49m
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.